Thymox maker nets $4.6 mln in Cycle, Desjardins-led Series B
Laboratoire M2 has raised $4.6 million in a Series B financing. The round was led by Canadian venture capital firms Cycle Capital Management and Desjardins-Innovatech, existing investors in the company. They were joined by new investors, including Germain Benoit of Gercanoit. Founded in 2003, Sherbrooke, Québec-based Laboratoire M2 is the maker of Thymox, a botanically-derived disinfectant for use in animal health and crop protection. Led by CEO Frank Palantoni, the company plans to utilize the funds raised to pivot from development of its Thymox technology to full-scale commercial expansion on three continents.
8 May 2017•4 mins read
